ARTICLES BY BERNHARD J. PAUL
-
![Fear Factors]( "5 Questions To Ask Your CDMO: #2 – Can You Tell Me About A Project Where Things Went Wrong?")
5 Questions To Ask Your CDMO: #2 – Can You Tell Me About A Project Where Things Went Wrong?10/2/2018Taking a potential drug from candidate selection through clinical development and eventual commercialization is a challenging process. It is not a question of if something unexpected will happen, but when. And when the inevitable problem occurs, how will your CDMO tackle this situation?
Bernhard J. Paul
Bernhard J Paul, Ph.D. is the founder and principal consultant at Carinth Consulting LLC, a drug development consulting firm based in the Boston area. Paul has worked within biotech and for multiple CDMOs in the U.S. and Europe, and he uses his extensive experience to advise companies on all aspects of small molecule development and strategy. Paul is the author of 21 U.S. patents and multiple peer reviewed articles. He holds a Ph.D. from the University of Florida and an undergraduate degree from the University of Graz, Austria. He can be contacted at bernhard.paul@carinthconsulting.com.